Literature DB >> 29842949

Evaluation of computational techniques for predicting non-synonymous single nucleotide variants pathogenicity.

Marwa S Hassan1, A A Shaalan2, M I Dessouky3, Abdelaziz E Abdelnaiem2, Mahmoud ElHefnawi4.   

Abstract

The human genetic diseases associated with many factors, one of these factors is the non-synonymous Single Nucleotide Variants (nsSNVs) cause single amino acid change with another resulting in protein function change leading to disease. Many computational techniques have been released to expect the impacts of amino acid alteration on protein function and classify mutations as pathogenic or neutral. Here in this article, we assessed the performance of eight techniques; FATHMM, SIFT, Provean, iFish, Mutation Assessor, PANTHER, SNAP2, and PON- P2 using a VaribenchSelectedPure dataset of 2144 pathogenic variants and 3777 neutral variants extracted from the free standard database "Varibench." The first five techniques achieve (45.60-83.75) % specificity, (52.64-94.13) % sensitivity, (51.00-88.90) % AUC, and (49.76-88.24) % ACC on whole dataset, while all eight techniques achieve (36.54-77.88) % specificity, (50.00-75.00) % sensitivity, (51.00-76.40) % AUC, and (25.00-77.78) % ACC on random sample dataset. We also created a Meta classifier (CSTJ48) that combines FATHMM, iFish, and Mutation Assessor. It registers 96.33% specificity, 86.07% sensitivity, 91.20% AUC, and 91.89 ACC. By comparing the results, it's clear that FATHMM gives the highest performance over the seven individual techniques, where it achieves 83.75% and 77.88% specificity, 94.13%, and 75.00% sensitivity, 88.90% and 76.40% AUC, and 88.24% and 77.78% ACC on whole and random sample dataset, respectively. Also, the launched Meta classifier (CSTJ48) is outperforming over all the eight individual tools that compared here.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computational techniques; FATHMM; Meta classifier (CSTJ48); Mutation Assessor; Neutral variants; Non-synonymous SNVs (nsSNVs); PANTHER; PON P2; Pathogenic variants; Provean; SIFT; SNAP2; iFish

Mesh:

Year:  2018        PMID: 29842949     DOI: 10.1016/j.ygeno.2018.05.013

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  17 in total

1.  Revealing modifier variations characterizations for elucidating the genetic basis of human phenotypic variations.

Authors:  Hong Sun; Xiaoping Lan; Liangxiao Ma; Junmei Zhou
Journal:  Hum Genet       Date:  2021-09-08       Impact factor: 5.881

2.  Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.

Authors:  Lauren A Marcath; Kelley M Kidwell; Kiran Vangipuram; Christina L Gersch; James M Rae; Monika L Burness; Jennifer J Griggs; Catherine Van Poznak; Daniel F Hayes; Ellen M Lavoie Smith; N Lynn Henry; Andreas S Beutler; Daniel L Hertz
Journal:  Br J Clin Pharmacol       Date:  2020-02-04       Impact factor: 4.335

Review 3.  Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good.

Authors:  Kristi Krebs; Lili Milani
Journal:  Hum Genomics       Date:  2019-08-27       Impact factor: 4.639

4.  PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma.

Authors:  Concetta D'Ambrosio; Jessica Erriquez; Maddalena Arigoni; Sonia Capellero; Gloria Mittica; Eleonora Ghisoni; Fulvio Borella; Dionyssios Katsaros; Silvana Privitera; Marisa Ribotta; Elena Maldi; Giovanna Di Nardo; Enrico Berrino; Tiziana Venesio; Riccardo Ponzone; Marco Vaira; Douglas Hall; Mercedes Jimenez-Linan; Anna L Paterson; Raffaele A Calogero; James D Brenton; Giorgio Valabrega; Maria Flavia Di Renzo; Martina Olivero
Journal:  Cells       Date:  2020-02-14       Impact factor: 7.666

5.  Type IV Collagen Variants in CKD: Performance of Computational Predictions for Identifying Pathogenic Variants.

Authors:  Cole Shulman; Emerald Liang; Misato Kamura; Khalil Udwan; Tony Yao; Daniel Cattran; Heather Reich; Michelle Hladunewich; York Pei; Judy Savige; Andrew D Paterson; Mary Ann Suico; Hirofumi Kai; Moumita Barua
Journal:  Kidney Med       Date:  2021-02-10

6.  Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer.

Authors:  Georgios I Papageorgiou; Evangelos Fergadis; Nikos Skouteris; Evridiki Christakos; Sergios A Tsakatikas; Evangelos Lianos; Christos Kosmas
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

7.  Clinical validation of genomic functional screen data: Analysis of observed BRCA1 variants in an unselected population cohort.

Authors:  Kelly M Schiabor Barrett; Max Masnick; Kathryn E Hatchell; Juliann M Savatt; Natalie Banet; Adam Buchanan; Huntington F Willard
Journal:  HGG Adv       Date:  2022-01-08

8.  Annotation of Human Exome Gene Variants with Consensus Pathogenicity.

Authors:  Victor Jaravine; James Balmford; Patrick Metzger; Melanie Boerries; Harald Binder; Martin Boeker
Journal:  Genes (Basel)       Date:  2020-09-14       Impact factor: 4.096

9.  Pathogenic nsSNPs that increase the risks of cancers among the Orang Asli and Malays.

Authors:  Nurul Ain Khoruddin; Mohd NurFakhruzzaman Noorizhab; Lay Kek Teh; Farida Zuraina Mohd Yusof; Mohd Zaki Salleh
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

10.  In Silico Tools for Analysis of Single-Nucleotide Polymorphisms in the Bovine Transferrin Gene.

Authors:  Aarif Ali; Muneeb U Rehman; Syed Mudasir Ahmad; Tabish Mehraj; Ishraq Hussain; Ahmed Nadeem; Manzoor Ur Rahman Mir; Showkat Ahmad Ganie
Journal:  Animals (Basel)       Date:  2022-03-10       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.